- Home
- VSTM vs CCIF Comparison
VSTM vs CCIF Comparison
Compare VSTM & CCIF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VSTM
- CCIF
- Stock Information
- Founded
- VSTM 2010
- CCIF 2011
- Country
- VSTM United States
- CCIF United States
- Employees
- VSTM N/A
- CCIF N/A
- Industry
- VSTM Biotechnology: Pharmaceutical Preparations
- CCIF Finance/Investors Services
- Sector
- VSTM Health Care
- CCIF Finance
- Exchange
- VSTM Nasdaq
- CCIF Nasdaq
- Market Cap
- VSTM 132.0M
- CCIF 110.5M
- IPO Year
- VSTM 2012
- CCIF N/A
- Fundamental
- Price
- VSTM $3.85
- CCIF $8.30
- Analyst Decision
- VSTM Strong Buy
- CCIF
- Analyst Count
- VSTM 8
- CCIF 0
- Target Price
- VSTM $14.57
- CCIF N/A
- AVG Volume (30 Days)
- VSTM 950.0K
- CCIF 76.9K
- Earning Date
- VSTM 11-06-2024
- CCIF 01-01-0001
- Dividend Yield
- VSTM N/A
- CCIF 25.90%
- EPS Growth
- VSTM N/A
- CCIF N/A
- EPS
- VSTM N/A
- CCIF N/A
- Revenue
- VSTM $10,000,000.00
- CCIF N/A
- Revenue This Year
- VSTM N/A
- CCIF N/A
- Revenue Next Year
- VSTM $108.05
- CCIF N/A
- P/E Ratio
- VSTM N/A
- CCIF N/A
- Revenue Growth
- VSTM N/A
- CCIF N/A
- 52 Week Low
- VSTM $2.10
- CCIF $7.43
- 52 Week High
- VSTM $14.22
- CCIF $10.16
- Technical
- Relative Strength Index (RSI)
- VSTM 54.40
- CCIF 52.79
- Support Level
- VSTM $3.71
- CCIF $8.13
- Resistance Level
- VSTM $4.29
- CCIF $8.32
- Average True Range (ATR)
- VSTM 0.33
- CCIF 0.10
- MACD
- VSTM -0.05
- CCIF 0.02
- Stochastic Oscillator
- VSTM 31.82
- CCIF 89.29
About VSTM Verastem Inc.
Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.
About CCIF Carlyle Credit Income Fund Shares of Beneficial Interest
Carlyle Credit Income Fund is a non-diversified, closed-end management investment company. The Fund's primary investment objective is to generate current income, with a secondary objective to generate capital appreciation. The Fund seeks to achieve its investment objective by investing primarily in equity and junior debt tranches of collateralized loan obligations, that are collateralized by a portfolio consisting primarily of below-investment-grade U.S. senior secured loans with a large number of distinct underlying borrowers across various industry sectors.